{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:02:54Z","timestamp":1790463774753,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.antiviral.2019.104691","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T17:57:27Z","timestamp":1576519047000},"page":"104691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D"],"prefix":"10.1016","volume":"174","author":[{"given":"Ben L.","family":"Da","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Surana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104691_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhep.2016.10.007","article-title":"Hepatitis delta-associated mortality in HIV\/HBV-coinfected patients","volume":"66","author":"Beguelin","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib2","first-page":"145","article-title":"The natural history of chronic delta hepatitis","volume":"234","author":"Bonino","year":"1987","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.antiviral.2019.104691_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ajg.2011.100","article-title":"A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C","volume":"106","author":"Boursier","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2019.104691_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0399-8320(08)73992-7","article-title":"FibroMeters: a family of blood tests for liver fibrosis","volume":"32","author":"Cales","year":"2008","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.antiviral.2019.104691_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2893.2009.01087.x","article-title":"Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis","volume":"16","author":"Castera","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.104691_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2893.2008.01037.x","article-title":"Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B","volume":"16","author":"Chan","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.104691_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.104691_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1148\/radiol.2015150887","article-title":"Spleen size is significantly influenced by body height and sex: establishment of normal values for spleen size at US with a cohort of 1200 healthy individuals","volume":"279","author":"Chow","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.antiviral.2019.104691_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jhep.2012.03.016","article-title":"ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study","volume":"57","author":"Crespo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","article-title":"Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study)","volume":"53","author":"Degos","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/MEG.0b013e328336ec84","article-title":"Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest","volume":"22","author":"El-Shabrawi","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)","volume":"46","author":"Fattovich","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.104691_bib13","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1478-3231.2012.02831.x","article-title":"HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome","volume":"32","author":"Heidrich","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2019.104691_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","article-title":"Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease","volume":"47","author":"Kim","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104691_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1478-3231.2009.02192.x","article-title":"Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients","volume":"30","author":"Kim","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2019.104691_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2015.11.012","article-title":"Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients","volume":"64","author":"Kim","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","volume":"1","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104691_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2015.04.025","article-title":"Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes","volume":"63","author":"Kushner","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib20","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/cncr.22242","article-title":"Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma","volume":"107","author":"Lu","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.antiviral.2019.104691_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1136\/gutjnl-2017-315299","article-title":"Assessment of liver fibrosis with the gamma-glutamyl transpeptidase to platelet ratio: a multicentre validation in patients with HBV infection","volume":"67","author":"Lu","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2019.104691_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/liv.13205","article-title":"Non-invasive fibrosis score for hepatitis delta","volume":"37","author":"Lutterkort","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2019.104691_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2010.06.008","article-title":"Outcome of chronic delta hepatitis in Italy: a long-term cohort study","volume":"53","author":"Niro","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib24","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jhep.2006.01.007","article-title":"Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C","volume":"44","author":"Sebastiani","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104691_bib25","doi-asserted-by":"crossref","first-page":"18131","DOI":"10.3748\/wjg.v20.i48.18131","article-title":"Non invasive tools for the diagnosis of liver cirrhosis","volume":"20","author":"Soresi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2019.104691_bib26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104691_bib27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/apt.13939","article-title":"Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience","volume":"45","author":"Takyar","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2019.104691_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/apt.13834","article-title":"Noninvasive markers for staging fibrosis in chronic delta hepatitis","volume":"45","author":"Takyar","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2019.104691_bib29","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104691_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","article-title":"Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis","volume":"95","author":"Williams","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.104691_bib31","first-page":"265","article-title":"Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience","volume":"28","author":"Yakoob","year":"2015","journal-title":"Ann. Gastroenterol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:06Z","timestamp":1759062666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":31,"alternative-id":["S0166354219304711"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104691","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Delta-4 fibrosis score (D4FS): A novel fibrosis score in chronic hepatitis D","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104691"}}